L G Rudenko

Author PubWeight™ 17.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine 2006 1.16
2 Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol 1995 1.04
3 Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. Clin Vaccine Immunol 2011 0.99
4 [Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses]. Vopr Virusol 1998 0.85
5 [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. Mol Gen Mikrobiol Virusol 2011 0.84
6 [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Vopr Virusol 1994 0.81
7 [Restriction analysis of genome composition of live influenza vaccine]. Vopr Virusol 2011 0.80
8 [Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009]. Vopr Virusol 2013 0.79
9 [PCR restriction analysis of the genome composition of reassortant cold-adapted influenza B virus strains]. Vopr Virusol 2007 0.78
10 [Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells]. Zh Mikrobiol Epidemiol Immunobiol 2008 0.78
11 [Phenotyte of epidemic influenza B virus strains isolated in different years]. Vopr Virusol 2006 0.78
12 [Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3]. Zh Mikrobiol Epidemiol Immunobiol 2009 0.78
13 [Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine]. Vopr Virusol 2012 0.77
14 Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Vaccine 1993 0.77
15 [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. Vopr Virusol 2002 0.77
16 [A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol 1992 0.77
17 [Effect of Point Mutations in the Polymerase Genes of the Influenza A/PR/8/34 (H1N1) Virus on the Immune Response in a Mouse Model]. Vopr Virusol 2015 0.77
18 Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol 1976 0.77
19 T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases. Acta Virol 1978 0.76
20 [The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14]. Vopr Virusol 1992 0.76
21 [Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]. Vopr Virusol 1996 0.76
22 [Production of interleukin-2 in vitro and in vivo in elderly people, vaccinated with live and inactivated flu vaccines separately and combined]. Vopr Virusol 2000 0.75
23 [The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children]. Vopr Virusol 2002 0.75
24 [Effect of non-specific inhibitors in horse serum on human adenoviruses]. Vopr Virusol 1972 0.75
25 [Dynamics of adenovirus reproduction in the liver of newborn hamsters and changes in humoral immunity factors in experimental adenovirus hepatitis]. Vopr Virusol 1972 0.75
26 [Reactogenic properties and the immunological activity of an absorbed influenza chemical vaccine]. Tr Inst Im Pastera 1976 0.75
27 Subunit influenza vaccine and its testing in clinical immunology. J Hyg Epidemiol Microbiol Immunol 1980 0.75
28 [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice]. Vopr Virusol 2007 0.75
29 [Dynamics of the antihemagglutinin level in annual human immunization with inactivated influenza vaccines]. Vopr Virusol 1986 0.75
30 [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine]. Vopr Virusol 2014 0.75
31 [Effect of repeated immunization with inactivated influenza vaccine on the formation of specific and nonspecific immunity factors]. Zh Mikrobiol Epidemiol Immunobiol 1984 0.75
32 [Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines]. Vopr Virusol 2013 0.75
33 [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Vopr Virusol 2003 0.75
34 [The use of the lectin test for detecting antineuraminidase antibodies in the sera of vaccinated subjects]. Vopr Virusol 1992 0.75
35 [Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. Vopr Virusol 1998 0.75
36 [The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2]. Vopr Virusol 2012 0.75
37 [The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old]. Vopr Virusol 1994 0.75
38 [Immunoenzyme analysis of post-vaccination secretory immunity to influenza A and B viruses using a manufactured monoclonal immunoenzyme test system]. Vopr Virusol 1998 0.75
39 [The formation of an immune response in volunteers inoculated with a live recombinant influenza vaccine]. Vopr Virusol 1992 0.75
40 [Immune response to live influenza vaccine]. Vestn Ross Akad Med Nauk 2002 0.75
41 [Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines]. Vopr Virusol 1998 0.75
42 [Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine]. Vopr Virusol 1989 0.75
43 Search for optimal scheme for administering live allantoic influenza vaccine. J Hyg Epidemiol Microbiol Immunol 1983 0.75
44 [The biological properties of 2 strains of adenovirus serotype 4]. Vopr Virusol 1972 0.75
45 [The International Scientific Conference on the Optimization of Influenza Control]. Vopr Virusol 1994 0.75
46 Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses. Vaccine 2006 0.75
47 [Vaccine prophylaxis of influenza in persons with chronic pathology]. Zh Mikrobiol Epidemiol Immunobiol 1982 0.75
48 [Humoral and local immune response to the influenza vaccine in people of old and young ages]. Vopr Virusol 2003 0.75
49 [Use of plant-origin components in roller cultivation of vaccine reassortant influenza virus strain H5N2]. Zh Mikrobiol Epidemiol Immunobiol 2011 0.75
50 [Cross protection in mice immunized with different anti-influenza preparations]. Vopr Virusol 1982 0.75
51 [B-cell and cytotoxic lymphocyte immune response to virulent, attenuated and reassortant influenza viruses]. Vopr Virusol 2002 0.75
52 [Study of the biology of intratype variants of adenovirus serotypes 1, 2, 3, 4 and 7]. Vestn Akad Med Nauk SSSR 1970 0.75
53 [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination]. Vopr Virusol 1989 0.75
54 [The results of state trials of inactivated influenza vaccines for children]. Zh Mikrobiol Epidemiol Immunobiol 1988 0.75
55 [Current strategies for vaccine prevention of influenza]. Vopr Virusol 1996 0.75
56 [Testing of apathogenic influenza virus H5N3 as a poultry live vaccine]. Vopr Virusol 2015 0.75
57 [Growth characteristics of single gene mutants of A/Leningrad/134/57(H2N2) influenza virus and cold-adapted mutant A/Leningrad/134/17/57(H2N2)]. Vopr Virusol 2007 0.75
58 Subunit influenza virus vaccine Grippovac SE-AZh (vaccination of adults). Acta Virol 1985 0.75
59 [The choice of the optimal schedules in the vaccination procedure against influenza in elderly subjects]. Zh Mikrobiol Epidemiol Immunobiol 1998 0.75
60 [Assessment of the effectiveness of inactivated influenza vaccines for adults]. Zh Mikrobiol Epidemiol Immunobiol 1986 0.75
61 [Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old]. Zh Mikrobiol Epidemiol Immunobiol 1988 0.75
62 [Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses]. Vopr Virusol 2006 0.75
63 [Codon optimization of hemagglutinin as a promising tool for improving of the influenza vaccines immunogenicity]. Mol Gen Mikrobiol Virusol 2014 0.75
64 Enhancement of protection against influenza by complex prophylactic schemes. J Hyg Epidemiol Microbiol Immunol 1980 0.75
65 [Local immune response to live cold-adapted reassortant influenza vaccine in children, adults, and aged people]. Vopr Virusol 2003 0.75
66 [Contribution of neuraminidase of influenza viruses to the sensitivity to the serum inhibitors and reassortment efficiency]. Mol Gen Mikrobiol Virusol 2014 0.75
67 [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. Vopr Virusol 2005 0.75
68 [A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol 1992 0.75
69 [Genetic stability of cold-adapted influenza viruses]. Vopr Virusol 2006 0.75
70 [Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes]. Vopr Virusol 2011 0.75
71 [Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B live influenza vaccine]. Zh Mikrobiol Epidemiol Immunobiol 2011 0.75
72 Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG. Acta Virol 1983 0.75
73 [Experience in using inactivated influenza vaccine with persons at "high risk"]. Tr Inst Im Pastera 1979 0.75
74 [Protection of the elderly against influenza (a review of the literature)]. Vrach Delo 1981 0.75
75 [Homologous and heterologous antibody induction in influenzal infection and immunization]. Vopr Virusol 1977 0.75
76 [Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype]. Vopr Virusol 2014 0.75
77 [Live influenza vaccine: laboratory markers of attenuation]. Vopr Virusol 2007 0.75
78 [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA]. Vopr Virusol 2016 0.75
79 [In vitro proliferative activity of lymphocytes from elderly persons after separate and combined immunization with live and inactivated flu vaccines]. Vopr Virusol 2000 0.75
80 [Comparative evaluation of the reactogenicity and antigenic activity of Soviet inactivated influenza vaccines]. Zh Mikrobiol Epidemiol Immunobiol 1984 0.75
81 [Immunogenicity of influenza virus H5N2 vaccine strain samples produced by roller cultivation in media with plant derived components]. Zh Mikrobiol Epidemiol Immunobiol 2011 0.75
82 [A preclinical trial of the reassortant influenza virus vaccine strain A/17/Quail/Hong Kong/97/84 (H9N2)]. Vopr Virusol 2015 0.75
83 [The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A]. Vopr Virusol 1990 0.75
84 [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine]. Zh Mikrobiol Epidemiol Immunobiol 2012 0.75